National Vision
EYE
16.82
+0.08
+0.48%
National Vision
US · EYE
#3082 by market cap
Listed 2017
16.82
+0.08
+0.48%
Live - 5344 symbols - heartbeat 265s ago
· 2026-10-07 20:02
After-hours
16.82
0.00%
- Market cap
- 1.33B
- P/E (TTM)i
- 27.13
- P/Bi
- 1.48
- EPSi
- 0.37
- Div yieldi
- 0.00%
- 52W posi
- 14%
Reader sentiment
Are you bullish or bearish on EYE?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
TopCloudAg (301556): Project timelines are weighing on near-term revenue; keep an eye on opportunities arising from business model evolution.CICC · 2026/8/28
-
Rating change
Guggenheim Maintains National Vision(EYE.US) With Buy Rating, Cuts Target Price to $27Market Newswire · 2026/9/11
-
Rating change
Cat Eye Entertainment (01896.HK): In the first half of 2026, overall box office growth was weighed down by a high base effect, while the summer season delivered strong performance.GF Securities · 2026/8/23
-
Rating change
Cat Eye Entertainment (1896.HK): Weak overall box office conditions weigh on earnings; attention focused on the performance of its slate of upcoming titles.Sealand Securities · 2026/8/25
-
Rating change
Aier Eye Hospital (300015): Earnings in the first half of 2026 are expected to be volatile, with the refractive surgery business posting rapid growth.开源证券 · 2026/8/28
-
Rating change
Aier Eye Hospital (300015): Revenue in 26H1 grew steadily, with outpatient visits and surgical procedures continuing to rise.Guosen Securities · 2026/8/28
-
Rating change
Cat Eye Entertainment (01896.HK): Film business under short-term pressure; summer box-office season showing signs of recovery; IP business expanding steadily.Western Securities · 2026/9/1
-
Company notice
Needs Well: Neezwell strengthens its IT infrastructure modernization services with an eye toward the AI era.JPX · 2026/9/8
-
Company notice
Aier Eye Hospital: Legal Opinion of Hunan Qiyuan Law Firm Regarding the First Extraordinary Shareholders' Meeting of Aier Eye Hospital Group Co., Ltd. for 2026SZSI · 2026/9/15
-
China Merchants Securities International: Humanoid robots enter mass delivery phase; supply chain shifts toward platformization and modularity. Keep an eye on Ubtech Robotics (09880) and others.Zhitong Finance · 2026/9/30
-
C-Mer Eye Care (03309.HK) repurchased 160,000 shares on October 5 at a cost of HK$125,700.Gelonghui Finance · 2026/10/5
-
Aier Eye Hospital (300015): Back tax payments impact short-term profits; H-share listing preparations strengthen internationalization.Citic Securities · 2026/9/30
-
Rating change
Shanghai Harbor (605598): Short-term profit margins under pressure; keep an eye on developments in the commercial space sector.Huatai Securities · 2026/9/3
-
Rating change
Barclays Maintains National Vision(EYE.US) With Buy Rating, Maintains Target Price $27Market Newswire · 2026/9/10
-
Rating change
Joyoung Co., Ltd. (002242): Keep an eye on the pace of subsequent domestic demand improvement and earnings recovery.Huatai Securities · 2026/8/25
-
Company notice
Needs Well: Promoting the development of data‑driven talent with an eye toward the AI era.JPX · 2026/9/29
-
Company notice
Xingqi Eye Medicine: Legal Opinion of King & Wood Mallesons Beijing on the Second Extraordinary Shareholders' Meeting of Shenyang Xingqi Eye Medicine Co., Ltd. for 2026SZSI · 2026/9/14
-
Company notice
Institution for a Global Society: "AI GROW," which boasts a track record of assessing non-cognitive skills across 125 million data points, supports the "connection between learning and society" with an eye toward children's success after graduation.JPX · 2026/10/2
-
ANI Pharmaceuticals To Present Data From SYNCHRONICITY Phase 4 Clinical Trial Of Fluocinolone Acetonide Intravitreal Implant In Patients With Chronic Non-Infectious Uveitis Affecting The Posterior Segment Of The Eye In Oral Presentation During Uveitis...Benzinga · 2026/9/30
-
On September 30, Chaoju Eye Care (02219) repurchased 36,500 shares for HK$88,200.Zhitong Finance · 2026/9/30
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 20:02:22 · For reference only, not investment advice and not tailored to your situation.